Press Releases

Jumpcode Genomics Exits Stealth Mode, Unveils Technology that Addresses the ‘Needle in the Haystack’ Problem of Molecular Biology

CARLSBAD, CA, UNITED STATES - Sep 17, 2020 - Jumpcode Genomics – a genome technology company founded by industry veterans in 2016 focused on improving the understanding of human disease – today exited stealth mode and announced the commercial launch of its CRISPRclean™ technology

Romain Madelaine, Ph.D., Joins MDI Biological Laboratory Faculty

BAR HARBOR, ME, UNITED STATES - Sep 17, 2020 - The MDI Biological Laboratory has announced that Romain Madelaine, Ph.D., has been appointed to the faculty as an assistant professor

Huntington Study Group Announces a Partnership with Prilenia Therapeutics to Conduct a Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease

ROCHESTER, NY, UNITED STATES - Sep 17, 2020 - The Huntington Study Group (“HSG”), a world leader in clinical research for Huntington’s Disease (HD), announces a partnership with Prilenia Therapeutics, a clinical stage biotech company led by Michael R

ZEISS enhances efficiency in multi-scale and multi-modal workflows

JENA, GERMANY - Sep 2, 2020 - Materials and Life Science researchers can now experience faster accessibility of deeper regions of interest when investigating samples in 3D

2bPrecise Wins Industry Innovation Award

RALEIGH, NC, UNITED STATES - Sep 16, 2020 - Fierce Healthcare released its annual Fierce Innovation Report this week, naming 2bPrecise the industry’s top clinical information management solution

Imvax Appoints Wendy DiCicco as New Board Member

PHILADELPHIA, PA - Sep 16, 2020 - Imvax, Inc., an emerging oncology leader that is revolutionizing immunotherapy for patients with malignant glioblastomas (GBM) and other solid tumors with significant unmet medical needs, today announced the appointment of Wendy DiCicco to its board of directors

Accumen Launches MyBloodHealth®, a Virtual Anemia Management Software Solution for the Perioperative Patient

PHOENIX, AZ - Sep 15, 2020 - Accumen Inc. is helping healthcare get better, faster. Today the company launched its first software-as-a-service (SaaS) solution, MyBloodHealth®, a hospital-based telehealth anemia management program with both perioperative and comprehensive blood management options

CANARIE Selects and Funds CanDIG Project to make Research Clinical Data FAIRer

TORONTO, ON, CANADA - Sep 15, 2020 -  With advances in imaging technologies, new wearable health devices, mobile devices allowing patients to provide survey responses everywhere, and increasingly integrated electronic health records, health data consented for advancing biomedical research has never been more plentiful – or complex

Adventist Health Enhances Online Access for Both New and Existing Patients with Kyruus and Cerner Collaboration

BOSTON, MA, UNITED STATES - Sep 15, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, and Cerner Corporation, a global healthcare technology company, today announced that Adventist Health, a faith-based, nonprofit integrated health system serving the West Coast and Hawaii, has enhanced its digital consumer access experience with integrated technology solutions from the two companies

Absolute Antibody Adds SeqPack™ Hybridoma Preservation Kit to Antibody Sequencing Service

REDCAR, UNITED KINGDOM - Sep 15, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the availability of the SeqPack™ Hybridoma Preservation Kit, which streamlines the sample submission process for hybridoma sequencing customers worldwide


CARY, NC - Sep 15, 2020 - For Immediate ReleaseCATO SMS ACQUIRES ARRAY BIOSTATISTICSGlobal Provider Expands Specialized Clinical Research Offering with Enhanced Biostatistical ServicesCARY, Nx

Profacgen Provides Data Analysis Service for Biological Discovery

SHIRLEY, NY, UNITED STATES - Sep 15, 2020 - Profacgen, a state-of-the-art protein service provider based in New York, established its own bioinformatics platform, which has emerged as a very sophisticated scientific infrastructure for bioinformatics involving computational facilities, to help explore, understand and analyze complex biological data in various biotechnological programs and projects

HiFiBiO Therapeutics Announces a Global Strategic Partnership with ABL Bio for the Co-Development of a SARS-CoV-2 Neutralizing Antibody

CAMBRIDGE, MA, UNITED STATES - Sep 14, 2020 - HiFiBiO Therapeutics, a clinical-stage multinational biotherapeutics company focused on the development of novel antibodies in immunomodulation, today announced a partnership agreement with South Korea-based ABL Bio to advance HFB30132A, a SARS-CoV-2 neutralizing antibody for the treatment of COVID-19 patients

WEP Clinical joins with Wren Healthcare to provide home healthcare services

LONDON, UNITED KINGDOM - Sep 14, 2020 - WEP Group Holdings Limited (WEP), a specialist CRO focused on delivering lifesaving drugs to patients that have an unmet clinical need, is expanding its capabilities by making a strategic investment in Wren Healthcare Limited (Wren), a successful and growing clinical nursing healthcare provider in the EU

Check4Cancer launches online service to provide fast cancer screening as thousands of people go untested in the Covid-19 pandemic

CAMBRIDGE, UNITED KINGDOM - Sep 14, 2020 - Check4Cancer, the provider of early cancer detection and genetic services, has launched its new brand and website bringing together all of its cancer services onto one platform

SciBite launches state-of-the-art AI platform for Life Sciences organisations

CAMBRIDGE, UNITED KINGDOM - Sep 11, 2020 - SciBite, the award-winning semantic technology company, today announced the launch of SciBiteAI, a state-of-the-art Artificial Intelligence software platform for leveraging machine learning models alongside semantic technologies to unlock insights into Life Sciences data

Positive Technologies: Vulnerabilities in PAN-OS could threaten internal networks security

FRAMINGHAM, MA, UNITED STATES - Sep 9, 2020 - Palo Alto Networks remediated vulnerabilities in PAN-OS (operating systems version 8.1 or later), which is used by Palo Alto Networks next-generation firewalls (NGFW)

Theratechnologies to Develop Tesamorelin for the Treatment of NASH in the General Population

MONTREAL, QC, CANADA - Sep 10, 2020 - Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it plans to pursue Phase 3 clinical development of tesamorelin for the treatment of Non-Alcoholic Steatohepatitis (NASH) in the general population

Salaso Health’s telemedicine and live exercise platform enable US healthcare teams to stay safely connected with COVID-19 patients

NEW YORK, NY, UNITED STATES - Sep 10, 2020 - In the current pandemic environment, face-to-face physical therapy visits are less viable due to increasing demands on the healthcare system, as well as the enactment of stay-at-home measures and the reticence of patients particularly those from at-risk groups to visit a clinic or hospital setting

Peer-reviewed Study by Optibrium Demonstrates the Value of Deep Learning for Imputation of Drug Discovery Data

CAMBRIDGE, UNITED KINGDOM - Sep 9, 2020 - Optibrium™, leading providers of software and services for drug discovery, today announced a peer-reviewed publication, ‘Practical Applications of Deep Learning to Impute Heterogeneous Drug Discovery Data’, in the Journal of Chemical Information and Modeling [1]